Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients
NCT01028547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2010-03-26
Summary
This is a randomised controlled double blinded clinical trial to determine the antiemetic efficacy and safety of either 8 mg of dexamethasone or normal saline (placebo) given 1 hour before induction of either spinal or general anaesthesia in 2 arms (of 150 each).
Conditions
- Postoperative Nausea and Vomiting
Interventions
- DRUG
-
single Bolus dose of dexamethasone 8mg
- OTHER
-
normal saline
2 ml 0.9% saline
Sponsors & Collaborators
-
Makerere University
lead OTHER
Principal Investigators
-
Tindimwebwa J V B, MD · Makerere university dept of anesthesia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Uganda
Study Locations
More Related Trials
-
Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery
NCT01013012 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
NCT02550795 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery
NCT06981754 ·Status: RECRUITING ·Phase: NA
-
The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation
NCT02768168 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Palmitate for PONV After Open Surgery
NCT06997419 ·Status: RECRUITING ·Phase: NA
-
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
NCT00152867 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Palmitate for PONV After Craniotomy
NCT06988124 ·Status: RECRUITING ·Phase: NA
-
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
NCT04430361 ·Status: UNKNOWN ·Phase: PHASE2
-
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
NCT00687011 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-emetic Prophylaxis With or Without Dexamethasone
NCT05242874 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer
NCT01116713 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
NCT00437229 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
NCT02846493 ·Status: UNKNOWN ·Phase: PHASE2
-
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
NCT03125941 ·Status: COMPLETED ·Phase: PHASE4
-
Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation
NCT01974024 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy
NCT01094990 ·Status: COMPLETED ·Phase: PHASE4
-
Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV
NCT04437017 ·Status: COMPLETED ·Phase: PHASE3
-
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
NCT01093690 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin
NCT04201769 ·Status: UNKNOWN ·Phase: PHASE3
-
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
NCT01370408 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
NCT00104403 ·Status: COMPLETED ·Phase: PHASE2
-
Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy
NCT06850454 ·Status: RECRUITING ·Phase: PHASE3
-
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
NCT00016380 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery
NCT01548209 ·Status: COMPLETED ·Phase: NA
-
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
NCT00366834 ·Status: COMPLETED ·Phase: PHASE3